Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Qungang Zhou"'
Publikováno v:
IEEE Access, Vol 10, Pp 73988-73996 (2022)
Chylous blood, a kind of abnormal blood with an increasing proportion, should be excluded from unpaid blood donation. Therefore, it is important to determine the level of chylous blood, to judge that whether blood is applicable. In this manuscript, t
Externí odkaz:
https://doaj.org/article/cd6610234b4b4fa1a1cd3be1baa66966
Publikováno v:
ChemElectroChem. 8:2778-2782
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f662db2d19f2a15fbec7555c21da91e
https://doi.org/10.1002/celc.202100466
https://doi.org/10.1002/celc.202100466
Publikováno v:
Future Virology. 16:181-190
Aim: Adeno-associated virus (AAV) is the most preferred gene therapy vector. The purpose of our research is to compare the infection tropism and gene expression efficiency of vitreous injection of recombinant AAVs (rAAVs) and their capsid mutants in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bbee5940233a49c287371eafdf0c757
https://doi.org/10.2217/fvl-2020-0096
https://doi.org/10.2217/fvl-2020-0096
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 150
Recombinant Adeno-associated virus(rAAV) is currently the most widely used gene delivery vector and has been successfully used in various disease models, benefiting from its low immunogenicity, almost no toxicity, and no reported pathogenicity in hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c61cd8972beb63aeeb0df34e262dfcea
https://pubmed.ncbi.nlm.nih.gov/35658223
https://pubmed.ncbi.nlm.nih.gov/35658223
Supplementary figure 1, The effect of genistein on the gene expression of rAAV vectors in human primary T cells A, Primary T cells were firstly treated with genistein(0.01um) for different times (0.5 h,1 h,2h) separately, then were transduce with rAA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58a06603e4974cf194e2ab62c4ba9a88
Publikováno v:
The journal of gene medicineREFERENCES. 22(4)
Background Use of chimeric antigen receptor (CAR) T cells has become a promising strategy in cancer immunotherapy. However, safety in clinical application is also one of the most controversial issues. Methods In the present study, we investigated the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9851d82316dec34733bdee142b65aa28
https://pubmed.ncbi.nlm.nih.gov/31901177
https://pubmed.ncbi.nlm.nih.gov/31901177